- SomaLogic offers a pioneering platform for the study and engineering of various proteins, which lends itself to a large number of diseases giving the company a large pipeline.
- The company’s business approach sees them partner with other companies, selling the rights to utilize their platforms in their research which provides revenue while keeping costs low.
- The company recently announced that it would lend its services to EPIC for a project that aims to analyze and understand cancer development to predict it in the future.
For further details see:
SomaLogic Inc: A Biopharmaceutical Company With An Excellent Upside